Jackelinne Y. Hayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jackelinne Y. Hayashi has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Keiji Tashima
Universidade Federal de São Paulo
4 shared publications Anita M. Tanaka-Azevedo
Butantan Institute
2 shared publicationsTassia Chiarelli
Departamento de Bioquimica, Escola Paulista de Medicina
2 shared publications- Adriana Simizo
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
1 shared publication - Alioscka A. Sousa
Federal University of São Paulo (UNIFESP)
1 shared publication Ana F. Popi
Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 4 September 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (10) , 5230-5245
Sexual Dimorphism and Intraspecific Toxin Variation in Crotalus durissus terrificus Venom: Insights from Proteomics, Peptidomics, and Structural Modeling
The venom of the South American rattlesnake Crotalus durissus terrificus (Cdt) is renowned for its minimalist yet highly toxic arsenal. Intraspecific variability in expressed proteoforms and toxin content has been previously observed in Cdt venom, resulting in heterogeneous biological activities. In light of this, our study conducted an in-depth mass spectrometry-based analysis, combined with structural prediction to comprehensively assess Cdt venom variability and sexual dimorphism. Using peptidomic analysis, we identified 76 native peptides within Cdt venom, predominantly (63%) associated with noncanonical processing of crotoxin subunits, and 9 novel peptides via de novo sequencing. Quantitative analysis showed increased abundance of two crotapotin-derived peptides in females, while three novel peptides were significantly increased in males. Through quantitative proteomics, we characterized a repertoire of 33 proteins, with over one-third displaying sex-based differences in abundance. Furthermore, variant analysis revealed 12 novel toxin variants, generally at lower abundance than previously described proteoforms. Predictive three-dimensional structure modeling revealed conserved scaffolds, suggesting preservation of their biological activities. Addressing venom variability provides valuable insights into the intricate variability of Cdt venom, contributing to the understanding of its biological, medical, and biotechnological implications.
- 4 September 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (10) , 5230-5245
Open AccessSexual Dimorphism and Intraspecific Toxin Variation in Crotalus durissus terrificus Venom: Insights from Proteomics, Peptidomics, and Structural Modeling
The venom of the South American rattlesnake Crotalus durissus terrificus (Cdt) is renowned for its minimalist yet highly toxic arsenal. Intraspecific variability in expressed proteoforms and toxin content has been previously observed in Cdt venom, resulting in heterogeneous biological activities. In light of this, our study conducted an in-depth mass spectrometry-based analysis, combined with structural prediction to comprehensively assess Cdt venom variability and sexual dimorphism. Using peptidomic analysis, we identified 76 native peptides within Cdt venom, predominantly (63%) associated with noncanonical processing of crotoxin subunits, and 9 novel peptides via de novo sequencing. Quantitative analysis showed increased abundance of two crotapotin-derived peptides in females, while three novel peptides were significantly increased in males. Through quantitative proteomics, we characterized a repertoire of 33 proteins, with over one-third displaying sex-based differences in abundance. Furthermore, variant analysis revealed 12 novel toxin variants, generally at lower abundance than previously described proteoforms. Predictive three-dimensional structure modeling revealed conserved scaffolds, suggesting preservation of their biological activities. Addressing venom variability provides valuable insights into the intricate variability of Cdt venom, contributing to the understanding of its biological, medical, and biotechnological implications.
- Open Access
- 16 December 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (51) , 42964-42978
Heparin-Binding Proteins in the Nanoparticle Corona Enhance Cellular Uptake through Glycocalyx Interactions
Nanoparticles (NPs) designed for intracellular delivery must first navigate the cell-surface glycocalyx before reaching the plasma membrane for internalization. Here, we hypothesized that the glycocalyx can both hinder NP uptake via a barrier effect and enhance uptake by providing recognition sites for corona proteins. To dissect these opposing mechanisms, we prepared NPs with plasma protein coronas either enriched or depleted in heparin-binding proteins (HBPs), along with model coronas containing selected HBPs or non-HBPs. Biophysical assays confirmed strong heparin interactions for HBP-rich NPs, whereas HBP-poor NPs showed weak or no binding. To assess the role of corona-glycocalyx interactions in NP uptake, we used glycocalyx-depleted cells, a chemical inhibitor, and heparin and antithrombin competition assays. We found that canonical HBPs within the protein corona, including antithrombin, apolipoprotein E, and platelet factor 4, significantly enhanced NP surface retention and internalization through protein-glycocalyx interactions. In contrast, HBP-poor NPs showed weak or no interactions with the glycocalyx and, correspondingly, reduced uptake. Significantly, these findings also extended to physiologically derived coronas from control and dyslipidemic sera, with the latter producing HBP-enriched coronas that bound more strongly to heparin and promoted more efficient glycocalyx-dependent NP uptake. These findings highlight the underappreciated role of the glycocalyx in actively engaging with coronal HBPs to drive efficient NP uptake. This insight underscores the need to expand corona engineering beyond membrane receptor interactions, incorporating strategies that optimize glycocalyx interactions for more effective NP delivery.
- 16 December 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (51) , 42964-42978
Open AccessHeparin-Binding Proteins in the Nanoparticle Corona Enhance Cellular Uptake through Glycocalyx Interactions
Nanoparticles (NPs) designed for intracellular delivery must first navigate the cell-surface glycocalyx before reaching the plasma membrane for internalization. Here, we hypothesized that the glycocalyx can both hinder NP uptake via a barrier effect and enhance uptake by providing recognition sites for corona proteins. To dissect these opposing mechanisms, we prepared NPs with plasma protein coronas either enriched or depleted in heparin-binding proteins (HBPs), along with model coronas containing selected HBPs or non-HBPs. Biophysical assays confirmed strong heparin interactions for HBP-rich NPs, whereas HBP-poor NPs showed weak or no binding. To assess the role of corona-glycocalyx interactions in NP uptake, we used glycocalyx-depleted cells, a chemical inhibitor, and heparin and antithrombin competition assays. We found that canonical HBPs within the protein corona, including antithrombin, apolipoprotein E, and platelet factor 4, significantly enhanced NP surface retention and internalization through protein-glycocalyx interactions. In contrast, HBP-poor NPs showed weak or no interactions with the glycocalyx and, correspondingly, reduced uptake. Significantly, these findings also extended to physiologically derived coronas from control and dyslipidemic sera, with the latter producing HBP-enriched coronas that bound more strongly to heparin and promoted more efficient glycocalyx-dependent NP uptake. These findings highlight the underappreciated role of the glycocalyx in actively engaging with coronal HBPs to drive efficient NP uptake. This insight underscores the need to expand corona engineering beyond membrane receptor interactions, incorporating strategies that optimize glycocalyx interactions for more effective NP delivery.
- Open Access
- 22 January 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 881-890
Enhancing the Bothropic Antivenom through a Reverse Antivenomics Approach
Antivenoms are the only effective treatment for snakebite envenomation and have saved countless lives over more than a century. Despite their value, antivenoms present risks of adverse reactions. Current formulations contain a fraction of nonspecific antibodies and serum proteins. While new promising candidates emerge as the next generation of antivenoms, it remains clear that animal-derived antivenoms will still play a critical role for years to come. In this study, we improved the bothropic antivenom (BAv), by capturing toxin-specific antibodies through affinity chromatography using immobilized Bothrops jararaca venom toxins. This process produced an improved antivenom (iBAv) enriched in neutralizing antibodies and depleted of serum proteins. Proteomic analysis showed that iBAv was 87% depleted in albumin and 37-83% lower in other serum proteins compared to BAv. Functional evaluation demonstrated that iBAv had a 2.9-fold higher affinity for venom toxins by surface plasmon resonance and a 2.8-fold lower ED50 in vivo, indicating enhanced potency. Our findings indicate that enriching specific antibodies while depleting serum proteins reduces the total protein dose required and increases the potency of antivenom. Although technical and economic considerations remain for large-scale implementation, this affinity-enriched antivenom represents a significant advancement in improving antivenom efficacy against B. jararaca envenomations.
- 22 January 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 881-890
Open AccessEnhancing the Bothropic Antivenom through a Reverse Antivenomics Approach
Antivenoms are the only effective treatment for snakebite envenomation and have saved countless lives over more than a century. Despite their value, antivenoms present risks of adverse reactions. Current formulations contain a fraction of nonspecific antibodies and serum proteins. While new promising candidates emerge as the next generation of antivenoms, it remains clear that animal-derived antivenoms will still play a critical role for years to come. In this study, we improved the bothropic antivenom (BAv), by capturing toxin-specific antibodies through affinity chromatography using immobilized Bothrops jararaca venom toxins. This process produced an improved antivenom (iBAv) enriched in neutralizing antibodies and depleted of serum proteins. Proteomic analysis showed that iBAv was 87% depleted in albumin and 37-83% lower in other serum proteins compared to BAv. Functional evaluation demonstrated that iBAv had a 2.9-fold higher affinity for venom toxins by surface plasmon resonance and a 2.8-fold lower ED50 in vivo, indicating enhanced potency. Our findings indicate that enriching specific antibodies while depleting serum proteins reduces the total protein dose required and increases the potency of antivenom. Although technical and economic considerations remain for large-scale implementation, this affinity-enriched antivenom represents a significant advancement in improving antivenom efficacy against B. jararaca envenomations.
- 27 February 2022
- Published by Elsevier in Journal of Infection
- Vol. 84 (6) , 834-872
Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2
- 27 February 2022
- Published by Elsevier in Journal of Infection
- Vol. 84 (6) , 834-872
Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2